Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Authors
Keywords
-
Journal
NATURE
Volume 572, Issue 7768, Pages 254-259
Publisher
Springer Science and Business Media LLC
Online
2019-07-18
DOI
10.1038/s41586-019-1410-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The NKG2D axis: an emerging target in cancer immunotherapy
- (2019) Mariya Lazarova et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice
- (2017) Anna M. Paczulla et al. HAEMATOLOGICA
- Tracing the origins of relapse in acute myeloid leukaemia to stem cells
- (2017) Liran I. Shlush et al. NATURE
- Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice
- (2017) Anna M. Paczulla et al. HAEMATOLOGICA
- GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo
- (2016) C. Pabst et al. BLOOD
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer
- (2016) Nidal E. Muvarak et al. CANCER CELL
- MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome
- (2016) Vaia Stavropoulou et al. CANCER CELL
- Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
- (2016) Srinivas Malladi et al. CELL
- A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
- (2016) Ivana Gojo et al. CLINICAL CANCER RESEARCH
- Genetically distinct leukemic stem cells in human CD34−acute myeloid leukemia are arrested at a hemopoietic precursor-like stage
- (2016) Lynn Quek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
- (2016) S P Koerner et al. LEUKEMIA
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
- (2016) Olga A Guryanova et al. NATURE MEDICINE
- IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression
- (2016) Xiaoran Zhang et al. NEURO-ONCOLOGY
- Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
- (2015) Maria Teresa Esposito et al. NATURE MEDICINE
- Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells
- (2015) Andreas Reinisch et al. SEMINARS IN HEMATOLOGY
- Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
- (2014) B. Wang et al. CANCER RESEARCH
- p19INK4d Controls Hematopoietic Stem Cells in a Cell-Autonomous Manner during Genotoxic Stress and through the Microenvironment during Aging
- (2014) Morgane Hilpert et al. Stem Cell Reports
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Acute myeloid leukaemia in adults
- (2013) Felicetto Ferrara et al. LANCET
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias
- (2012) N. A. Zorko et al. BLOOD
- Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
- (2012) J. Hilpert et al. JOURNAL OF IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction
- (2011) Maya Caroline André et al. INTERNATIONAL JOURNAL OF CANCER
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
- (2011) M. Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
- (2010) D. C. Taussig et al. BLOOD
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
- (2010) Raga Krishnakumar et al. MOLECULAR CELL
- Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
- (2009) F. Reim et al. CANCER RESEARCH
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now